UiPath Inc. (NYSE:PATH) Shares Acquired by Ieq Capital LLC

Ieq Capital LLC lifted its position in shares of UiPath Inc. (NYSE:PATH) by 2.7% during the 2nd quarter, according to its most recent disclosure with the SEC. The firm owned 1,446,816 shares of the healthcare company’s stock after buying an additional 37,642 shares during the period. Ieq Capital LLC owned 0.25% of UiPath worth $18,346,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Vanguard Group Inc. increased its stake in shares of UiPath by 5.6% during the 1st quarter. Vanguard Group Inc. now owns 40,217,936 shares of the healthcare company’s stock valued at $911,741,000 after acquiring an additional 2,133,078 shares during the last quarter. State Board of Administration of Florida Retirement System raised its stake in UiPath by 0.5% during the first quarter. State Board of Administration of Florida Retirement System now owns 295,370 shares of the healthcare company’s stock worth $6,696,000 after purchasing an additional 1,571 shares during the period. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of UiPath by 4.2% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 231,694 shares of the healthcare company’s stock valued at $5,240,000 after purchasing an additional 9,393 shares during the last quarter. Acadian Asset Management LLC grew its stake in shares of UiPath by 245.1% during the 1st quarter. Acadian Asset Management LLC now owns 45,700 shares of the healthcare company’s stock valued at $1,032,000 after buying an additional 32,456 shares during the period. Finally, Neuberger Berman Group LLC increased its holdings in shares of UiPath by 38.4% during the 4th quarter. Neuberger Berman Group LLC now owns 20,133 shares of the healthcare company’s stock worth $500,000 after buying an additional 5,586 shares during the last quarter. Institutional investors and hedge funds own 62.50% of the company’s stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on the company. TD Cowen reduced their target price on UiPath from $17.00 to $16.00 and set a “hold” rating on the stock in a report on Friday, September 6th. Canaccord Genuity Group reduced their price objective on UiPath from $30.00 to $19.00 and set a “buy” rating on the stock in a research note on Friday, May 31st. Royal Bank of Canada reissued a “sector perform” rating and set a $16.00 target price on shares of UiPath in a research report on Friday, September 6th. Macquarie downgraded shares of UiPath from an “outperform” rating to a “neutral” rating and decreased their price objective for the stock from $29.00 to $12.00 in a research note on Monday, June 3rd. Finally, Needham & Company LLC reaffirmed a “hold” rating on shares of UiPath in a research report on Friday, September 6th. Sixteen investment analysts have rated the stock with a hold rating and two have assigned a buy rating to the stock. Based on data from MarketBeat, the company has a consensus rating of “Hold” and an average target price of $17.71.

Insiders Place Their Bets

In other news, CFO Ashim Gupta sold 47,671 shares of UiPath stock in a transaction that occurred on Friday, September 13th. The stock was sold at an average price of $12.07, for a total transaction of $575,388.97. Following the sale, the chief financial officer now owns 849,917 shares of the company’s stock, valued at $10,258,498.19. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 22.37% of the stock is owned by insiders.

UiPath Trading Up 1.2 %

Shares of UiPath stock opened at $12.45 on Friday. The stock has a market capitalization of $7.13 billion, a price-to-earnings ratio of -77.81 and a beta of 0.87. UiPath Inc. has a twelve month low of $10.37 and a twelve month high of $27.87. The business’s 50 day simple moving average is $12.12 and its 200-day simple moving average is $16.03.

UiPath (NYSE:PATH) last announced its quarterly earnings results on Thursday, September 5th. The healthcare company reported $0.04 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.03 by $0.01. UiPath had a negative net margin of 8.13% and a negative return on equity of 3.98%. The company had revenue of $316.00 million during the quarter, compared to the consensus estimate of $303.69 million. During the same quarter in the previous year, the company posted ($0.09) earnings per share. The company’s revenue for the quarter was up 10.0% compared to the same quarter last year. Sell-side analysts predict that UiPath Inc. will post -0.23 earnings per share for the current year.

About UiPath

UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.